BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 34088286)

  • 1. Health care cost and benefits of artificial intelligence-assisted population-based glaucoma screening for the elderly in remote areas of China: a cost-offset analysis.
    Xiao X; Xue L; Ye L; Li H; He Y
    BMC Public Health; 2021 Jun; 21(1):1065. PubMed ID: 34088286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness and cost-utility of population-based glaucoma screening in China: a decision-analytic Markov model.
    Tang J; Liang Y; O'Neill C; Kee F; Jiang J; Congdon N
    Lancet Glob Health; 2019 Jul; 7(7):e968-e978. PubMed ID: 31122906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data.
    Lin S; Ma Y; Xu Y; Lu L; He J; Zhu J; Peng Y; Yu T; Congdon N; Zou H
    JMIR Public Health Surveill; 2023 Feb; 9():e41624. PubMed ID: 36821353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis.
    Liu H; Li R; Zhang Y; Zhang K; Yusufu M; Liu Y; Mou D; Chen X; Tian J; Li H; Fan S; Tang J; Wang N
    Lancet Glob Health; 2023 Mar; 11(3):e456-e465. PubMed ID: 36702141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China.
    Huang XM; Yang BF; Zheng WL; Liu Q; Xiao F; Ouyang PW; Li MJ; Li XY; Meng J; Zhang TT; Cui YH; Pan HW
    BMC Health Serv Res; 2022 Feb; 22(1):260. PubMed ID: 35216586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness and cost utility of community screening for glaucoma in urban India.
    John D; Parikh R
    Public Health; 2017 Jul; 148():37-48. PubMed ID: 28404532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of community screening for glaucoma in rural India: a decision analytical model.
    John D; Parikh R
    Public Health; 2018 Feb; 155():142-151. PubMed ID: 29407529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness analysis of artificial intelligence-based diabetic retinopathy screening in rural China based on the Markov model.
    Li H; Li G; Li N; Liu C; Yuan Z; Gao Q; Hao S; Fan S; Yang J
    PLoS One; 2023; 18(11):e0291390. PubMed ID: 37971984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of Phacoemulsification Versus Combined Phacotrabeculectomy for Treating Primary Angle Closure Glaucoma.
    Chan PP; Li EY; Tsoi KKF; Kwong YY; Tham CC
    J Glaucoma; 2017 Oct; 26(10):911-922. PubMed ID: 28858162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of glaucoma in a rural northern china adult population: a population-based survey in kailu county, inner mongolia.
    Song W; Shan L; Cheng F; Fan P; Zhang L; Qu W; Zhang Q; Yuan H
    Ophthalmology; 2011 Oct; 118(10):1982-8. PubMed ID: 21684607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prevalence and its effective factors of primary angle-closure glaucoma in defined populations of rural and urban in Beijing].
    Xu L; Zhang L; Xia CR; Li JJ; Hu LN; Ma K; Chen YJ; Fan GZ; Song WX; Shi YY; Zhang SY; Sun BC
    Zhonghua Yan Ke Za Zhi; 2005 Jan; 41(1):8-14. PubMed ID: 15774106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National and subnational prevalence and burden of glaucoma in China: A systematic analysis.
    Song P; Wang J; Bucan K; Theodoratou E; Rudan I; Chan KY
    J Glob Health; 2017 Dec; 7(2):020705. PubMed ID: 29302324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prevalence of blindness caused by primary angle closure glaucoma in middle-aged Chinese population: a systematic review and meta-analysis].
    Liu ML; Wang YX
    Zhonghua Yan Ke Za Zhi; 2017 May; 53(5):373-377. PubMed ID: 28494566
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prevalence of primary glaucoma among adults aged 50 years or above population in Huamu community: a cross-sectional survey in Shanghai, 2011].
    He J; Zou H; Tong X; Zhang S; Zhao R; Zhang Y; Zhou W; Tang W; Ge L
    Zhonghua Yan Ke Za Zhi; 2014 May; 50(5):349-54. PubMed ID: 25052804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors for angle-closure disease in a rural Northeast China population: a population-based survey in Bin County, Harbin.
    Qu W; Li Y; Song W; Zhou X; Kang Y; Yan L; Sui H; Yuan H
    Acta Ophthalmol; 2011 Sep; 89(6):e515-20. PubMed ID: 21834920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population impact and cost-effectiveness of artificial intelligence-based diabetic retinopathy screening in people living with diabetes in Australia: a cost effectiveness analysis.
    Hu W; Joseph S; Li R; Woods E; Sun J; Shen M; Jan CL; Zhu Z; He M; Zhang L
    EClinicalMedicine; 2024 Jan; 67():102387. PubMed ID: 38314061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of primary angle closure and primary angle-closure glaucoma in a southwestern rural population of Japan: the Kumejima Study.
    Sawaguchi S; Sakai H; Iwase A; Yamamoto T; Abe H; Tomita G; Tomidokoro A; Araie M
    Ophthalmology; 2012 Jun; 119(6):1134-42. PubMed ID: 22361313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angle-closure glaucoma in an urban population in southern India. The Andhra Pradesh eye disease study.
    Dandona L; Dandona R; Mandal P; Srinivas M; John RK; McCarty CA; Rao GN
    Ophthalmology; 2000 Sep; 107(9):1710-6. PubMed ID: 10964834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and risk factors for primary glaucomas in adult urban and rural populations in the Andhra Pradesh Eye Disease Study.
    Garudadri C; Senthil S; Khanna RC; Sannapaneni K; Rao HB
    Ophthalmology; 2010 Jul; 117(7):1352-9. PubMed ID: 20188420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness and cost-utility of a digital technology-driven hierarchical healthcare screening pattern in China.
    Wu X; Wu Y; Tu Z; Cao Z; Xu M; Xiang Y; Lin D; Jin L; Zhao L; Zhang Y; Liu Y; Yan P; Hu W; Liu J; Liu L; Wang X; Wang R; Chen J; Xiao W; Shang Y; Xie P; Wang D; Zhang X; Dongye M; Wang C; Ting DSW; Liu Y; Pan R; Lin H
    Nat Commun; 2024 Apr; 15(1):3650. PubMed ID: 38688925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.